MRD / Regn No. : THBC\23-24\03796 Date : 29/06/2026
Patient Name : Saleem Reshamvala Age & Gender : 67 Yrs. / Male
Contact No. : 9820093776 UHID :
Ht / Wt / BMI : 168 / 65.6 / 23.24 BP S / BP D : 125 / 74
Allergies : NONE Referred By :
   
Problem List : T2DM (09/Mar/2011) | DYSLIPIDEMIA (03/Mar/2021) |
Subjective : T2DM SINCE 2011,DYSLIPIDEMIA,UNSTABLE ANGINA - MULTIVESSEL DISEASE - BOTH STENTS DONE
Objective : 23-JUN-2026 REPORTS,HBA1C-7.2%,FBS-163
Plan : NOT CONSIDERING GLP1 AT THIS TIME  
S# Generic (Trade) Name Route Dosage Usage Duration
1 ZILDA M (50/1000) ORAL 1-0-1 BEFORE BREAKFAST / BEFORE DINNER
 3 MTHS
2 RECLIDE MR 30 MG ORAL 0-0-1 BEFORE DINNER
 3 MTHS
3 TABLET ROSUVASTATIN 5MG
RAZEL 5 MG 		ORAL 0-0-1 AD- 3 DAYS A WEEK
 3 MTHS
4 VIT D 60K ORAL 1/15 DAYS ANYTIME OF DAY
 TO CONTINUE
5 SAROGLITAZAAR 4 MG
LIPAGLYN 4 MG 		ORAL 1-0-0 BEFORE BREAKFAST
 3 MTHS
       
Refill : 0 / Substitution:    
Education : IF LOW SUGARS (<70 MG/DL),TAKE 1 TBSP(15GMS) GLUCOSE POWDER. CHECK AGAIN AFTER 15 MINS IF >100 CAN GIVE A PROTEIN MEAL.
Next Visit : 29/Sep/2026
Tests Suggested For Next Visit : HBA1C / FBS / PPBS > 3 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: